E. Weinberg

Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol‐associated hepatitis

John P. Rice, Jordan P. Davis, B. Dilkina, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.

J. Chan, D. Rockey, P. Thuluvath, 2020, Journal of hepatology.

Survival and liver recompensation after declined for early liver transplantation for severe alcohol-associated hepatitis

N. Terrault, Matthew Dukewich, M. Shoreibah, 2022, Journal of Hepatology.

Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

N. Terrault, Matthew Dukewich, M. Shoreibah, 2023, Hepatology.

Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis

J. Chan, E. Schiff, K. Reddy, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion

Douglas A. Simonetto, D. Simonetto, K. Jamil, 2023, Contemporary clinical trials communications.

Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin

K. Jamil, F. Wong, E. Weinberg, 2023, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.